Matches in SemOpenAlex for { <https://semopenalex.org/work/W2186810301> ?p ?o ?g. }
- W2186810301 endingPage "489" @default.
- W2186810301 startingPage "489" @default.
- W2186810301 abstract "Dipeptidyl peptidase-4 (DPP-4) inhibitor add-on therapy is a new option for patients with inadequately controlled type 2 diabetes who are taking combined metformin and sulfonylurea (SU). We evaluated the efficacy and safety of this triple therapy and the characteristics of rapid responders and hypoglycemia-prone patients.We included 807 patients with type 2 diabetes who were prescribed a newly added DPP-4 inhibitor to ongoing metformin and SU in 2009 to 2011. Glycemia and other metabolic parameters at baseline, 12, 24, and 52 weeks, as well as episodes of hypoglycemia were analyzed. Rapid responders were defined as patients with ≥25% reduction in glycosylated hemoglobin (HbA1c) within 12 weeks.At baseline, while on the submaximal metformin and SU combination, the mean HbA1c level was 8.4%. Twelve weeks after initiation of DPP-4 inhibitor add-on, 269 patients (34.4%) achieved an HbA1c level ≤7%. Sixty-six patients (8.2%, 47 men) were rapid responders. The duration of diabetes was shorter in rapid responders, and their baseline fasting plasma glucose (FPG), HbA1c, C-peptide, and homeostasis model assessment of insulin resistance were significantly higher. Patients who experienced hypoglycemia after taking DPP-4 inhibitor add-on were more likely to be female, to have a lower body weight and lower triglyceride and FPG levels, and to have higher homeostasis model assessment of β-cells.An oral hypoglycemic triple agent combination including a DPP-4 inhibitor was effective in patients with uncontrolled diabetes. Proactive dose reduction of SU should be considered when a DPP-4 inhibitor is added for rapid responders and hypoglycemia-prone patients." @default.
- W2186810301 created "2016-06-24" @default.
- W2186810301 creator A5004080830 @default.
- W2186810301 creator A5008074124 @default.
- W2186810301 creator A5009982632 @default.
- W2186810301 creator A5021543854 @default.
- W2186810301 creator A5055042656 @default.
- W2186810301 creator A5065410551 @default.
- W2186810301 creator A5071083018 @default.
- W2186810301 creator A5082648255 @default.
- W2186810301 creator A5083444011 @default.
- W2186810301 creator A5090460555 @default.
- W2186810301 date "2015-01-01" @default.
- W2186810301 modified "2023-10-16" @default.
- W2186810301 title "Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin" @default.
- W2186810301 cites W1526600040 @default.
- W2186810301 cites W1586263023 @default.
- W2186810301 cites W1678283822 @default.
- W2186810301 cites W1728748816 @default.
- W2186810301 cites W1885709862 @default.
- W2186810301 cites W1975588287 @default.
- W2186810301 cites W1981302806 @default.
- W2186810301 cites W1994832750 @default.
- W2186810301 cites W2019470196 @default.
- W2186810301 cites W2024314573 @default.
- W2186810301 cites W2045046262 @default.
- W2186810301 cites W2061212570 @default.
- W2186810301 cites W2078037416 @default.
- W2186810301 cites W2100159536 @default.
- W2186810301 cites W2104058374 @default.
- W2186810301 cites W2110382695 @default.
- W2186810301 cites W2116675597 @default.
- W2186810301 cites W2131402106 @default.
- W2186810301 cites W2147698512 @default.
- W2186810301 cites W2159260370 @default.
- W2186810301 cites W2159859567 @default.
- W2186810301 cites W2160234571 @default.
- W2186810301 cites W2163153907 @default.
- W2186810301 cites W2325963726 @default.
- W2186810301 cites W2607031541 @default.
- W2186810301 doi "https://doi.org/10.4093/dmj.2015.39.6.489" @default.
- W2186810301 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4696985" @default.
- W2186810301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26616595" @default.
- W2186810301 hasPublicationYear "2015" @default.
- W2186810301 type Work @default.
- W2186810301 sameAs 2186810301 @default.
- W2186810301 citedByCount "1" @default.
- W2186810301 countsByYear W21868103012016 @default.
- W2186810301 crossrefType "journal-article" @default.
- W2186810301 hasAuthorship W2186810301A5004080830 @default.
- W2186810301 hasAuthorship W2186810301A5008074124 @default.
- W2186810301 hasAuthorship W2186810301A5009982632 @default.
- W2186810301 hasAuthorship W2186810301A5021543854 @default.
- W2186810301 hasAuthorship W2186810301A5055042656 @default.
- W2186810301 hasAuthorship W2186810301A5065410551 @default.
- W2186810301 hasAuthorship W2186810301A5071083018 @default.
- W2186810301 hasAuthorship W2186810301A5082648255 @default.
- W2186810301 hasAuthorship W2186810301A5083444011 @default.
- W2186810301 hasAuthorship W2186810301A5090460555 @default.
- W2186810301 hasBestOaLocation W21868103011 @default.
- W2186810301 hasConcept C126322002 @default.
- W2186810301 hasConcept C134018914 @default.
- W2186810301 hasConcept C156490143 @default.
- W2186810301 hasConcept C2776453732 @default.
- W2186810301 hasConcept C2776999253 @default.
- W2186810301 hasConcept C2777180221 @default.
- W2186810301 hasConcept C2777391703 @default.
- W2186810301 hasConcept C2778763485 @default.
- W2186810301 hasConcept C2778854520 @default.
- W2186810301 hasConcept C2780323712 @default.
- W2186810301 hasConcept C2780668416 @default.
- W2186810301 hasConcept C3018667095 @default.
- W2186810301 hasConcept C555293320 @default.
- W2186810301 hasConcept C71924100 @default.
- W2186810301 hasConcept C90924648 @default.
- W2186810301 hasConcept C98274493 @default.
- W2186810301 hasConceptScore W2186810301C126322002 @default.
- W2186810301 hasConceptScore W2186810301C134018914 @default.
- W2186810301 hasConceptScore W2186810301C156490143 @default.
- W2186810301 hasConceptScore W2186810301C2776453732 @default.
- W2186810301 hasConceptScore W2186810301C2776999253 @default.
- W2186810301 hasConceptScore W2186810301C2777180221 @default.
- W2186810301 hasConceptScore W2186810301C2777391703 @default.
- W2186810301 hasConceptScore W2186810301C2778763485 @default.
- W2186810301 hasConceptScore W2186810301C2778854520 @default.
- W2186810301 hasConceptScore W2186810301C2780323712 @default.
- W2186810301 hasConceptScore W2186810301C2780668416 @default.
- W2186810301 hasConceptScore W2186810301C3018667095 @default.
- W2186810301 hasConceptScore W2186810301C555293320 @default.
- W2186810301 hasConceptScore W2186810301C71924100 @default.
- W2186810301 hasConceptScore W2186810301C90924648 @default.
- W2186810301 hasConceptScore W2186810301C98274493 @default.
- W2186810301 hasIssue "6" @default.
- W2186810301 hasLocation W21868103011 @default.
- W2186810301 hasLocation W21868103012 @default.
- W2186810301 hasLocation W21868103013 @default.
- W2186810301 hasLocation W21868103014 @default.
- W2186810301 hasLocation W21868103015 @default.